Abeta-IN-9 (Compound 6i) is an amyloid beta-protein (Abeta) aggregation inhibitor. This compound effectively prevents the formation of nanorod structures by inhibiting Abeta aggregation, thereby blocking beta-sheet formation. Abeta-IN-9 is applicable in Alzheimers disease research.
Formula:
C17H17NO5
Target:
Beta Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted
